Acadian Asset Management
IGC icon

Acadian Asset Management’s IGC Pharma IGC Stock Holding History

Acadian Asset Management’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,876
Closed -$1K – 1457
2017
Q2 		$1K Buy
+2,876
New +$1.28K ﹤0.01% 1413

Other funds holding IGC

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Acadian Asset Management's IGC Position: Q3 2017 in Review

Acadian Asset Management sold out of IGC Pharma (IGC) in Q3 2017, closing a stake of 2,876 shares — an estimated $1K sold.

Acadian Asset Management first reported a position in IGC in Q2 2017 and held it in 1 quarter. The position peaked at $1K in Q2 2017. 6 funds tracked by Wall St. Rank hold IGC as of Q3 2017.

  • Acadian Asset Management reported no remaining IGC Pharma position as of Q3 2017 after selling out during the quarter.
  • Acadian Asset Management sold 2,876 IGC Pharma shares in Q3 2017, an estimated $1K.
  • Acadian Asset Management first reported a position in IGC Pharma in Q2 2017 and held it in 1 quarter.
  • Acadian Asset Management's IGC Pharma position peaked at $1K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2017.

Based on Acadian Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.